1 / 8

Hematology Oncology market

Hematology Oncology market

Mayuri24
Download Presentation

Hematology Oncology market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hematology Oncology Market Trends, Size, Share, Demands, Overview, Growth, Revenue and Forecast to 2030 sales@delvens.comwww.delvens.com

  2. Sternal Closure Systems Market – Trends Forecast Till 2030 Hematology Oncology Market, by Hematology Product (Hematology Analyzers, Hematology Reagents, Flow Cytometers, Hematology Cell Counters, Slide Strainers, Coagulation Analyzers, Hematology Testing, Centrifuges, Hemoglobin meters, Others), Oncology Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), Oncology Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others), end users, and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). Request For Free Sample Report: https://www.delvens.com/get-free-sample/hematology-oncology-market sales@delvens.com www.delvens.com

  3. Market Overview Hematology oncology is a medical specialty that focuses on the diagnosis, treatment, and management of blood disorders (hematology) and cancer (oncology). Hematology oncologists are trained to handle conditions such as leukemia, lymphoma, multiple myeloma, and other blood related cancers, as well as solid tumors. They use a combination of chemotherapy, radiation therapy, targeted therapy, immunotherapy, and other advanced treatments to provide comprehensive care to patients with these conditions. The hematology oncology market is expected to grow during the forecast period. This growth can be attributed to the rise in the prevalence of lymphoma and myeloma, rise in the healthcare infrastructure and rise in the geriatric population all over the world. Moreover, the availability of more sophisticated molecular techniques for the diagnosis of hemato oncology has also increased. In addition, increased demand for laboratory automation, and more awareness of preventative healthcare are expected to drive the market during the forecast period. Purchase this Report: https://www.delvens.com/checkout/hematology-oncology-market sales@delvens.com www.delvens.com

  4. Key Findings The Hematology Oncology market is segmented into Product, drug class type, oncology indication, end users, and region: Based on the product, the market is segmented into hematology analyzers, hematology reagents, flow cytometers, hematology cell counters, slide strainers, coagulation analyzers, hematology testing, centrifuges, hemoglobin meters, others. The hematology analyzers dominated the market in this segment. Based on the drug class type, the market is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy. sales@delvens.com www.delvens.com

  5. Key Findings Based on oncology indication, the market is bifurcated into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer, others. Leukemia dominated the market in this segment. This is due to the high incidence of leukemia, the development of new leukemia treatments, and the increased demand for personalized cancer therapies. The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/hematology-oncology-market sales@delvens.com www.delvens.com

  6. Competitive Landscape • Agilent Technologies Inc. • Beijing Genomics Institute • Caris Life Sciences • Eurofins Scientific • F. Hoffmann-La Roche Ltd. • Foundation Medicine Inc. • Illumina, Inc. • Myriad Genetics Inc. • Oxford Nanopore Technologies plc. • PacBio • Paradigm Diagnostics Inc. • Partek Incorporated • Perkin Elmer Inc. • Qiagen • Thermo Fisher Scientific Inc. sales@delvens.com www.delvens.com

  7. Recent Developments In June 2022, Thermo Fisher Scientific Inc. expanded its extensive line of automated connective tissue disease tests by releasing the new EliA RNA Pol III and EliA Rib-P blood tests to assist in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus (SLE). In 2022, F. Hoffman-La Roche Ltd. Received FDA approval for the cobras EZH2 mutation test as a companion diagnostic for patients with follicular lymphoma. sales@delvens.com www.delvens.com

  8. Contact Information About Us: Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally. Contact Us: +44-20-3290-6466 +1 214-377-1144 sales@delvens.com sales@delvens.com www.delvens.com

More Related